Europe Sexually Transmitted Diseases Diagnostics Market Size, Share & Trends Analysis Report By Disease Type/Pathogen (Chlamydia trachomatis, Neisseria gonorrhoeae (Gonorrhea) , Human Immunodeficiency Virus (HIV) , Human Papillomavirus (HPV) ), By Diagnostic Technology/Type (Laboratory-Based TestsPCR (Polymerase Chain Reaction) ELISA (Enzyme-Linked Immunosorbent Assay) NAAT (Nucleic Acid Amplification Test) Cell Culture , Rapid Point-of-Care (POC) Tests  Lateral Flow Assays Immunochromatographic Tests , Other Technologies Western Blot Direct Fluorescent Antibody (DFA) Flow Cytometry ), By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux) and Forecast, 2026-2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Europe Sexually Transmitted Diseases Diagnostics Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Europe Sexually Transmitted Diseases Diagnostics Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Europe Sexually Transmitted Diseases Diagnostics Market, By Type
   1. Introduction
      1. Market Size and Forecast, By Type
   2. Chlamydia
      1. Market Size and Forecast, By Region
   3. Gonorrhea
      1. Market Size and Forecast, By Region
   4. Syphilis
      1. Market Size and Forecast, By Region
   5. HPV
      1. Market Size and Forecast, By Region
   6. HIV
      1. Market Size and Forecast, By Region
   7. HSV
      1. Market Size and Forecast, By Region
   8. Other STDs
      1. Market Size and Forecast, By Region
10. Europe Sexually Transmitted Diseases Diagnostics Market, By Technology
    1. Introduction
       1. Market Size and Forecast, By Technology
    2. Molecular Diagnostics
       1. Market Size and Forecast, By Region
    3. Immunoassays
       1. Market Size and Forecast, By Region
    4. Point-of-Care Testing
       1. Market Size and Forecast, By Region
    5. Other Technologies
       1. Market Size and Forecast, By Region
11. Europe Sexually Transmitted Diseases Diagnostics Market, By End-User
    1. Introduction
       1. Market Size and Forecast, By End-User
    2. Hospitals and Clinics
       1. Market Size and Forecast, By Region
    3. Diagnostic Laboratories
       1. Market Size and Forecast, By Region
    4. Home Care Settings
       1. Market Size and Forecast, By Region
    5. Others
       1. Market Size and Forecast, By Region
12. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. Europe
       1. Market Size and Forecast
          1. By Type
             1. Chlamydia
             2. Gonorrhea
             3. Syphilis
             4. HPV
             5. HIV
             6. HSV
             7. Other STDs
          2. By Technology
             1. Molecular Diagnostics
             2. Immunoassays
             3. Point-of-Care Testing
             4. Other Technologies
          3. By End-User
             1. Hospitals and Clinics
             2. Diagnostic Laboratories
             3. Home Care Settings
             4. Others
       2. United Kingdom
          1. By Type
             1. Chlamydia
             2. Gonorrhea
             3. Syphilis
             4. HPV
             5. HIV
             6. HSV
             7. Other STDs
          2. By Technology
             1. Molecular Diagnostics
             2. Immunoassays
             3. Point-of-Care Testing
             4. Other Technologies
          3. By End-User
             1. Hospitals and Clinics
             2. Diagnostic Laboratories
             3. Home Care Settings
             4. Others
       3. Germany
       4. France
       5. Spain
       6. Italy
       7. Russia
       8. Nordic
       9. Benelux
       10. Rest of Europe
13. Competitive Landscape, 2025
    1. Introduction
    2. Europe Sexually Transmitted Diseases Diagnostics Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
14. Company Profile
    1. Roche Diagnostics (Europe Operations)
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Abbott Laboratories (Europe Operations)
    3. Becton, Dickinson and Company (Europe Operations)
    4. Danaher Corporation (Cepheid Europe)
    5. BioMérieux SA
    6. Hologic, Inc. (Europe Operations)
    7. Thermo Fisher Scientific Inc. (Europe Operations)
    8. Qiagen N.V.
    9. Quidel Corporation (Europe Operations)
    10. Meridian Bioscience, Inc. (Europe Operations)
    11. Siemens Healthineers AG (Europe Operations)
    12. Beckman Coulter, Inc. (Europe Operations)
    13. Fujirebio Diagnostics, Inc. (Europe Operations)
    14. BD Biosciences (Europe Operations)
    15. Sysmex Corporation (Europe Operations)